Document Detail


Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double blind randomized clinical trial.
MedLine Citation:
PMID:  21993383     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: We studied the effect of pioglitazone on insulin levels, inflammation markers, high-density lipoprotein (HDL) composition and subclasses distribution, in young women with uncomplicated systemic lupus erythematosus (SLE). Methods: This double-blind trial included 30 premenopausal women (30 ±8 years old) with SLE, who were randomized to pioglitazone (30 mg/day) or placebo treatment for 3 months. Plasma and HDL lipids were determined by colorimetric enzymatic assays, insulin by radioimmunometric assay, inflammation by immunonephelometry and HDL size and subclasses distribution by a native 4-30% polyacrylamide gradient gel electrophoresis. Results: Compared with placebo, pioglitazone significantly increased HDL-cholesterol plasma levels (14.2%), reduced fasting insulin plasma levels (23.6%) and the homeostasis model assessment-insulin resistance (31.7%). C-reactive protein (70.9%) and serum amyloid A (34.9%) were also significantly reduced with the pioglitazone use, whereas the HDL particle size was increased (8.80 nm vs. 8.95 nm; p = 0.044) by changes in the distribution of HDL(2b), HDL(3b), and HDL(3c) subclasses. The change in HDL size correlated with a rise in free and cholesterol-ester content in the HDL particles. Conclusion: Pioglitazone significantly enhanced insulin sensitivity, reduced inflammation, and modified HDL characteristics, suggesting a potential beneficial effect of this drug in patients with SLE with a risk to develop cardiovascular disease. Trial registration: This trial is registered at ClinicalTrials.gov Protocol Registration System, with the number NCT01322308.
Authors:
J G Juárez-Rojas; A X Medina-Urrutia; E Jorge-Galarza; N A Caracas-Portilla; R Posadas-Sánchez; G C Cardoso-Saldaña; M V Goycochea-Robles; L H Silveira; L Lino-Pérez; J Mas-Oliva; O A Pérez-Méndez; C Posadas-Romero
Related Documents :
11361173 - The effects of laparoscopic adjustable gastric banding on the proximal pouch and the es...
11404233 - Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healt...
9555573 - Effect of adrenergic stimulation on clearance from small ciliated airways in healthy su...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-12
Journal Detail:
Title:  Lupus     Volume:  -     ISSN:  1477-0962     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204265     Medline TA:  Lupus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Endocrinology Department, National Institute of Cardiology ''Ignacio Chávez'', Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from th...
Next Document:  Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a co...